Company Overview

Company name: FSD-Pharma (CNQ: HUGE)
Description: Producer and distributor of medicinal cannabinoid extracts, recreational cannabis and industrial hemp products. The company’s product promote responsible use for medicinal purposes, backed by scientific research and innovation, while following strict compliance with standards for quality and safety, enabling developers and end users to control risks and efficiently manage its usage.
Year founded: 1994
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Cobourg
State: Ontario
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 7.50
Business status: Generating Revenue
Ownership: Publicly Held
Exchange: CNQ
Ticker: HUGE
Revenue (USD Million): 0.00
Gross profit (USD Million):
Net income (USD Million) 0.04
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA): 0.04
Fiscal period: TTM 2Q2018
Financing Status: The company (CNQ:HUGE) received $7.5 million of development capital from Auxly Cannabis Group on September 20, 2018 through a private placement. Proceeds of the financing will be deployed toward construction of the 220,000 square foot cultivation footprint that FSD and Auxly are jointly developing pursuant to their strategic alliance and streaming agreement previously announced on March 5, 2018.
Number of active investors:
Profile last updated: 23-Nov-2018
Last known valuation:
Last known valuation date: